|
RFC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99840144432528E-15 |
| Normal-vs-Stage2 |
5.431900E-04 |
| Normal-vs-Stage3 |
3.89460000005393E-06 |
| Normal-vs-Stage4 |
4.18070000000048E-05 |
| Stage1-vs-Stage2 |
2.736400E-01 |
| Stage1-vs-Stage3 |
1.478320E-02 |
| Stage1-vs-Stage4 |
2.011900E-02 |
| Stage2-vs-Stage3 |
2.849200E-01 |
| Stage2-vs-Stage4 |
4.874000E-01 |
| Stage3-vs-Stage4 |
5.647800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
7.91989807069626E-11 |
| Normal-vs-Asian |
4.451900E-02 |
| Caucasian-vs-AfricanAmerican |
7.014800E-01 |
| Caucasian-vs-Asian |
2.682400E-01 |
| AfricanAmerican-vs-Asian |
3.726800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.57571741713036E-14 |
| Male-vs-Female |
9.810500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.56949999850087E-08 |
| Normal-vs-Extreme_Weight |
2.04600003606004E-10 |
| Normal-vs-Obese |
1.08058006986766E-12 |
| Normal-vs-Extreme_Obese |
7.238200E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.355400E-01 |
| Normal_Weight-vs-Obese |
3.509200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.760600E-01 |
| Extreme_Weight-vs-Obese |
2.042400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.486200E-01 |
| Obese-vs-Extreme_Obese |
9.525600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.408300E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
5.787700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.091500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.796500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.084400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.078790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.120600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.364000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
4.81699999888008E-08 |
| Normal-VS-KIRP CIMP |
9.225000E-04 |
| Normal-VS-Unclassified PRCC |
1.61203999999859E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.605200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.081700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.317600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.009900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.218200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.747500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.24600005050269E-09 |
| Normal-vs-N1 |
2.114399999531E-07 |
| Normal-vs-N2 |
3.224600E-01 |
| N0-vs-N1 |
7.995700E-04 |
| N0-vs-N2 |
5.239400E-01 |
| N1-vs-N2 |
9.370200E-01 |
|
|
